Heterozygous loss of WBP11 function causes multiple congenital defects in humans and mice.

TitleHeterozygous loss of WBP11 function causes multiple congenital defects in humans and mice.
Publication TypeJournal Article
Year of Publication2020
AuthorsMartin, EMMA, Enriquez, A, Sparrow, DB, Humphreys, DT, McInerney-Leo, AM, Leo, PJ, Duncan, EL, Iyer, KR, Greasby, JA, Ip, E, Giannoulatou, E, Sheng, D, Wohler, E, Dimartino, C, Amiel, J, Capri, Y, Lehalle, D, Mory, A, Wilnai, Y, Lebenthal, Y, Gharavi, AG, Krzemień, GG, Miklaszewska, M, Steiner, RD, Raggio, C, Blank, R, Feldman, HBaris, Rasouly, HMilo, Sobreira, NLM, Jobling, R, Gordon, CT, Giampietro, PF, Dunwoodie, SL, Chapman, G
JournalHum Mol Genet
Volume29
Issue22
Pagination3662-3678
Date Published2020 12 04
ISSN1460-2083
Abstract

The genetic causes of multiple congenital anomalies are incompletely understood. Here, we report novel heterozygous predicted loss-of-function (LoF) and predicted damaging missense variants in the WW domain binding protein 11 (WBP11) gene in seven unrelated families with a variety of overlapping congenital malformations, including cardiac, vertebral, tracheo-esophageal, renal and limb defects. WBP11 encodes a component of the spliceosome with the ability to activate pre-messenger RNA splicing. We generated a Wbp11 null allele in mouse using CRISPR-Cas9 targeting. Wbp11 homozygous null embryos die prior to E8.5, indicating that Wbp11 is essential for development. Fewer Wbp11 heterozygous null mice are found than expected due to embryonic and postnatal death. Importantly, Wbp11 heterozygous null mice are small and exhibit defects in axial skeleton, kidneys and esophagus, similar to the affected individuals, supporting the role of WBP11 haploinsufficiency in the development of congenital malformations in humans. LoF WBP11 variants should be considered as a possible cause of VACTERL association as well as isolated Klippel-Feil syndrome, renal agenesis or esophageal atresia.

DOI10.1093/hmg/ddaa258
Alternate JournalHum Mol Genet
PubMed ID33276377
PubMed Central IDPMC7823106
Grant ListFS/17/55/33100 / BH / British Heart Foundation / United Kingdom
P50 HD103538 / HD / NICHD NIH HHS / United States
R03 HD099516 / HD / NICHD NIH HHS / United States
R01 DK080099 / DK / NIDDK NIH HHS / United States
UM1 HG006542 / HG / NHGRI NIH HHS / United States